Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

COVID-19 first and delta waves in relation to ACEI, ARB, Influenza vaccination, and comorbidity in a North Metropolitan Barcelona Health Consortium

Marta Juanes-González, Ana Calderón-Valdiviezo, Helena Losa-Puig, Roger Valls-Foix, Marta González-Salvador, Marc León-Pérez, Luís Pueyo-Antón, Celia Lozano-Paz, Maite Franco-Romero, View ORCID ProfileJosep Vidal-Alaball, View ORCID ProfileAnna Puigdellívol-Sánchez
doi: https://doi.org/10.1101/2021.11.17.21265440
Marta Juanes-González
aCAP Anton de Borja, c/ Marconi-cantonada Edison s/n, Terrassa Health Consortium (THC), 08191 Rubí. Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ana Calderón-Valdiviezo
aCAP Anton de Borja, c/ Marconi-cantonada Edison s/n, Terrassa Health Consortium (THC), 08191 Rubí. Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helena Losa-Puig
aCAP Anton de Borja, c/ Marconi-cantonada Edison s/n, Terrassa Health Consortium (THC), 08191 Rubí. Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roger Valls-Foix
aCAP Anton de Borja, c/ Marconi-cantonada Edison s/n, Terrassa Health Consortium (THC), 08191 Rubí. Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marta González-Salvador
bManagement, Control and Information Analysis Unit. Hospital de Terrassa. Carretera de Torrebonica s/n. 08227 Terrassa, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc León-Pérez
aCAP Anton de Borja, c/ Marconi-cantonada Edison s/n, Terrassa Health Consortium (THC), 08191 Rubí. Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luís Pueyo-Antón
aCAP Anton de Borja, c/ Marconi-cantonada Edison s/n, Terrassa Health Consortium (THC), 08191 Rubí. Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Celia Lozano-Paz
aCAP Anton de Borja, c/ Marconi-cantonada Edison s/n, Terrassa Health Consortium (THC), 08191 Rubí. Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maite Franco-Romero
aCAP Anton de Borja, c/ Marconi-cantonada Edison s/n, Terrassa Health Consortium (THC), 08191 Rubí. Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Josep Vidal-Alaball
cHealth Promotion in Rural Areas Research Group, Catalan Health Institute, 08272 Sant Fruitós de Bages, Spain
dCentral Catalonia Research Support Unit. Foundation University Institute for Primary Health Care Research Jordi Gol i Gurina. 08007 Barcelona, Spain
eFaculty of Health Sciences of Manresa and Faculty of Medicine, Carretera de Roda 70, 08500 Vic, University of Vic-Central University of Catalonia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Josep Vidal-Alaball
Anna Puigdellívol-Sánchez
aCAP Anton de Borja, c/ Marconi-cantonada Edison s/n, Terrassa Health Consortium (THC), 08191 Rubí. Spain
eFaculty of Health Sciences of Manresa and Faculty of Medicine, Carretera de Roda 70, 08500 Vic, University of Vic-Central University of Catalonia, Spain
fHuman Anatomy and Embryology Unit, Faculty of Medicine, c/Casanova 143, 08036 Barcelona, University of Barcelona. Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anna Puigdellívol-Sánchez
  • For correspondence: apuigdellivol@cst.cat
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

BACKGROUND Some authors have reported that angiotensin converter enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) improve clinical outcomes in hypertensive COVID-19 patients, and others have proposed cross-protection for influenza vaccination. This study explores the impact of these variables on the evolution of hospitalized patients, focusing in the first wave and the Delta wave.

METHODS Hospitalizations (n=1888) from March 1, 2020, to July 31, 2021, in the Hospital of Terrassa, the referral center for the free access Terrassa Health Consortium in the North Metropolitan Barcelona Health Region (population=167,386) were studied. The number of chronic treatments and conditions of patients from the initial outbreak (n=184) and the Delta outbreak (n=158) were recorded.

RESULTS Of the non-survivors, 96.3% were aged >60 years in the first wave and 100% were aged >70 years in the Delta wave. In non-survival hospitalized patients aged >60 years, the percentage treated with ACEI was similar to general population but was significantly different for ARB treatments of influenza vaccination, although associated to a higher comorbidity and age. In July 2021, the number of hospitalizations for patients aged <50 years was higher than March 2020 and 22% of hospitalized patients without chronic treatments and conditions needed admission to the intensive care unit. Mortality was reduced in the groups with most comorbidities who received influenza and SARS-CoV2 vaccination.

CONCLUSIONS In COVID-19 infection, age and comorbidity are related to survival, ACEI use is safe. A high proportion of patients without comorbidity require hospitalization and intensive care.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study did not receive any funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The ethics commitee 'Comite de Etica de Investigacion con medicamentos' of 'Consorci Sanitari de Terrassa' gave ethical aproval of this work (02-20-161-021).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • CONFLICTS OF INTEREST: The authors certify that there are no conflicts of interest with any financial organization regarding the material discussed in the manuscript.

  • FUNDING: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted November 19, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
COVID-19 first and delta waves in relation to ACEI, ARB, Influenza vaccination, and comorbidity in a North Metropolitan Barcelona Health Consortium
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
COVID-19 first and delta waves in relation to ACEI, ARB, Influenza vaccination, and comorbidity in a North Metropolitan Barcelona Health Consortium
Marta Juanes-González, Ana Calderón-Valdiviezo, Helena Losa-Puig, Roger Valls-Foix, Marta González-Salvador, Marc León-Pérez, Luís Pueyo-Antón, Celia Lozano-Paz, Maite Franco-Romero, Josep Vidal-Alaball, Anna Puigdellívol-Sánchez
medRxiv 2021.11.17.21265440; doi: https://doi.org/10.1101/2021.11.17.21265440
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
COVID-19 first and delta waves in relation to ACEI, ARB, Influenza vaccination, and comorbidity in a North Metropolitan Barcelona Health Consortium
Marta Juanes-González, Ana Calderón-Valdiviezo, Helena Losa-Puig, Roger Valls-Foix, Marta González-Salvador, Marc León-Pérez, Luís Pueyo-Antón, Celia Lozano-Paz, Maite Franco-Romero, Josep Vidal-Alaball, Anna Puigdellívol-Sánchez
medRxiv 2021.11.17.21265440; doi: https://doi.org/10.1101/2021.11.17.21265440

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (215)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1093)
  • Dentistry and Oral Medicine (195)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (499)
  • Epidemiology (9757)
  • Forensic Medicine (5)
  • Gastroenterology (480)
  • Genetic and Genomic Medicine (2303)
  • Geriatric Medicine (222)
  • Health Economics (462)
  • Health Informatics (1553)
  • Health Policy (732)
  • Health Systems and Quality Improvement (602)
  • Hematology (236)
  • HIV/AIDS (501)
  • Infectious Diseases (except HIV/AIDS) (11631)
  • Intensive Care and Critical Care Medicine (616)
  • Medical Education (236)
  • Medical Ethics (67)
  • Nephrology (256)
  • Neurology (2139)
  • Nursing (134)
  • Nutrition (335)
  • Obstetrics and Gynecology (426)
  • Occupational and Environmental Health (517)
  • Oncology (1172)
  • Ophthalmology (363)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (145)
  • Palliative Medicine (50)
  • Pathology (309)
  • Pediatrics (694)
  • Pharmacology and Therapeutics (298)
  • Primary Care Research (265)
  • Psychiatry and Clinical Psychology (2172)
  • Public and Global Health (4645)
  • Radiology and Imaging (775)
  • Rehabilitation Medicine and Physical Therapy (455)
  • Respiratory Medicine (623)
  • Rheumatology (274)
  • Sexual and Reproductive Health (225)
  • Sports Medicine (208)
  • Surgery (250)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)